We've got fresh evidence for how weight can quickly be regained after weight-loss programs stop – but rather than looking at ...

GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema.

For older adults with diabetes, there is no evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.

For older patients with cancer and T2D, GLP-1 RA use is associated with lower all-cause mortality than DPP4i use.

Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...

Empower Pharmacy, a Houston-based compounding pharmacy, has been sanctioned by the FDA and other states in the past decade.

A woman is speaking out after her successful attempt to buy weight-loss drug Mounjaro by using a ‘before’ image of another ...

China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...

For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is ...

HealthDay News — Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...